after stopping glp 1 Heart benefits are erased if patients stop taking GLP-1 medications, a large new study finds. https://cnn.it/4772ftO Most Patients with Type 2

Animal studies suggest it can restore esophageal sphincter tone and reduce inflammation, which may benefit chronic reflux sufferers

The warning is based on: Rodent studies Rodents given GLP-1 drugs developed: thyroid C-cell tumors medullary thyroid carcinoma other C-cell proliferative lesions Lack of long-term human studies There is no reliable 1020 year data to rule out similar risks in humans

We have previously reported the development of a hypotonic, gel-forming eye drop vehicle that provided therapeutic drug delivery to the posterior segment in rabbits and pigs [20]

Accessed February 5, 2018

& Saxena, S

doi: 10.7759/cureus.56737 28 FrhlichE.WahlR